A5225/HiFLAC is a Phase I/II dose escalation and validation study of the safety, tolerability, and therapeutic effect of an...
The purpose of this study is to determine whether one or two four-month regimens of tuberculosis treatment are as effective as a...
Study of MDR TB Cases and Their Household Contacts: Operational Feasibility to Inform PHOENIx Trial Design
Efavirenz (EFV) is an anti-HIV medicine that is commonly used to treat HIV infection in adults and children older than 3 years...
The study is being done with people who are taking their first anti-HIV drug regimen (including an Non-Nucleoside Reverse...
